Table of Contents

1 Study Coverage

• 1.1 Emphysema Drug Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Emphysema Drug Market Size Growth Rate by Product
  • 1.4.2 BB-3
  • 1.4.3 EDO-66
  • 1.4.4 MG-53
  • 1.4.5 Others
• 1.5 Market by End User
  • 1.5.1 Global Emphysema Drug Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Emphysema Drug Market Size
  • 2.1.1 Global Emphysema Drug Revenue 2014-2025
  • 2.1.2 Global Emphysema Drug Sales 2014-2025
• 2.2 Emphysema Drug Growth Rate by Regions
  • 2.2.1 Global Emphysema Drug Sales by Regions
  • 2.2.2 Global Emphysema Drug Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Emphysema Drug Sales by Manufacturers
  • 3.1.1 Emphysema Drug Sales by Manufacturers
  • 3.1.2 Emphysema Drug Sales Market Share by Manufacturers
  • 3.1.3 Global Emphysema Drug Market Concentration Ratio (CR5 and HHI)
• 3.2 Emphysema Drug Revenue by Manufacturers
  • 3.2.1 Emphysema Drug Revenue by Manufacturers (2014-2019)
  • 3.2.2 Emphysema Drug Revenue Share by Manufacturers (2014-2019)
• 3.3 Emphysema Drug Price by Manufacturers
• 3.4 Emphysema Drug Manufacturing Base Distribution, Product Types
  • 3.4.1 Emphysema Drug Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Emphysema Drug Product Type
  • 3.4.3 Date of International Manufacturers Enter into Emphysema Drug Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Emphysema Drug Sales by Product
• 4.2 Global Emphysema Drug Revenue by Product
• 4.3 Emphysema Drug Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Emphysema Drug Breakdown Data by End User

6 North America

• 6.1 North America Emphysema Drug by Countries
  • 6.1.1 North America Emphysema Drug Sales by Countries
  • 6.1.2 North America Emphysema Drug Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Emphysema Drug by Product
• 6.3 North America Emphysema Drug by End User

7 Europe

• 7.1 Europe Emphysema Drug by Countries
  • 7.1.1 Europe Emphysema Drug Sales by Countries
  • 7.1.2 Europe Emphysema Drug Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Emphysema Drug by Product
• 7.3 Europe Emphysema Drug by End User

8 Asia Pacific

• 8.1 Asia Pacific Emphysema Drug by Countries
  • 8.1.1 Asia Pacific Emphysema Drug Sales by Countries
  • 8.1.2 Asia Pacific Emphysema Drug Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Emphysema Drug by Product
• 8.3 Asia Pacific Emphysema Drug by End User

9 Central & South America

• 9.1 Central & South America Emphysema Drug by Countries
  • 9.1.1 Central & South America Emphysema Drug Sales by Countries
  • 9.1.2 Central & South America Emphysema Drug Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Emphysema Drug by Product
• 9.3 Central & South America Emphysema Drug by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Emphysema Drug by Countries
  • 10.1.1 Middle East and Africa Emphysema Drug Sales by Countries
  • 10.1.2 Middle East and Africa Emphysema Drug Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Emphysema Drug by Product
• 10.3 Middle East and Africa Emphysema Drug by End User

11 Company Profiles

• 11.1 Angion Biomedica Corp.
  • 11.1.1 Angion Biomedica Corp. Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Angion Biomedica Corp. Emphysema Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Angion Biomedica Corp. Emphysema Drug Products Offered
  • 11.1.5 Angion Biomedica Corp. Recent Development
• 11.2 ProMetic Life Sciences Inc.
  • 11.2.1 ProMetic Life Sciences Inc. Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 ProMetic Life Sciences Inc. Emphysema Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 ProMetic Life Sciences Inc. Emphysema Drug Products Offered
  • 11.2.5 ProMetic Life Sciences Inc. Recent Development
• 11.3 rEVO Biologics, Inc.
  • 11.3.1 rEVO Biologics, Inc. Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 rEVO Biologics, Inc. Emphysema Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 rEVO Biologics, Inc. Emphysema Drug Products Offered
  • 11.3.5 rEVO Biologics, Inc. Recent Development
• 11.4 SATT North SAS
  • 11.4.1 SATT North SAS Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 SATT North SAS Emphysema Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 SATT North SAS Emphysema Drug Products Offered
  • 11.4.5 SATT North SAS Recent Development
• 11.5 TGV-Laboratories
  • 11.5.1 TGV-Laboratories Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 TGV-Laboratories Emphysema Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 TGV-Laboratories Emphysema Drug Products Offered
  • 11.5.5 TGV-Laboratories Recent Development

12 Future Forecast

• 12.1 Emphysema Drug Market Forecast by Regions
  • 12.1.1 Global Emphysema Drug Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Emphysema Drug Revenue Forecast by Regions 2019-2025
• 12.2 Emphysema Drug Market Forecast by Product
  • 12.2.1 Global Emphysema Drug Sales Forecast by Product 2019-2025
  • 12.2.2 Global Emphysema Drug Revenue Forecast by Product 2019-2025
• 12.3 Emphysema Drug Market Forecast by End User
• 12.4 North America Emphysema Drug Forecast
• 12.5 Europe Emphysema Drug Forecast
• 12.6 Asia Pacific Emphysema Drug Forecast
• 12.7 Central & South America Emphysema Drug Forecast
• 12.8 Middle East and Africa Emphysema Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Emphysema Drug Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Emphysema Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Emphysema Drug market based on company, product type, end user and key regions.

This report studies the global market size of Emphysema Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Emphysema Drug in these regions.
This research report categorizes the global Emphysema Drug market by top players/brands, region, type and end user. This report also studies the global Emphysema Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Angion Biomedica Corp.
ProMetic Life Sciences Inc.
rEVO Biologics, Inc.
SATT North SAS
TGV-Laboratories

Market size by Product
BB-3
EDO-66
MG-53
Others
Market size by End User
Hospital
Clinic
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Emphysema Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Emphysema Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Emphysema Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Emphysema Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Emphysema Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Emphysema Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.